Disappearance of fibrosis in secondary myelofibrosis after ruxolitinib treatment: new endpoint to achieve?
Crossref DOI link: https://doi.org/10.1007/s00277-014-2096-y
Published Online: 2014-05-07
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Molica, Matteo
Serrao, Alessandra
Saracino, Roberta
Zacheo, Irene
Stingone, Christof
Alimena, Giuliana
Breccia, Massimo
Text and Data Mining valid from 2014-05-07